Bcl-x is required for proper development of the mouse substantia nigra

被引:126
作者
Savitt, JM
Jang, SS
Mu, WT
Dawson, VL
Dawson, TM
机构
[1] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Dept Internal Med, Sch Med, Div Gastroenterol, Baltimore, MD 21205 USA
关键词
Parkinson; Bcl-x; catecholamine; substantia nigra; dopamine; tyrosine hydroxylase;
D O I
10.1523/JNEUROSCI.0760-05.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent findings have uncovered a role for the Bcl-x gene in the survival of dopaminergic neurons. The exact nature of this role has been difficult to examine because of the embryonic lethality of Bcl-x gene disruption in mouse models. Here we report the generation of catecholaminergic cell-specific conditional Bcl-x gene knock-out mice using Cre-1ox recombination technology. First we produced transgenic mice that express Cre recombinase from an exogenous rat tyrosine hydroxylase promoter (TH-Cre mice). These mice were crossed to Z/AP and Z/EG reporter mouse strains to verify catecholaminergic (TH-positive) cell-specific Cre expression. The TH-Cre mice then were mated to mice possessing the Bcl-x gene flanked by loxP sites, thereby producing offspring with Bcl-x deletion limited to catecholaminergic cells. The resulting mice are viable but have one-third fewer catecholaminergic neurons than do control animals. They demonstrate a deficiency in striatal dopamine and also tend to be smaller and have decreased brain mass when compared with controls. Surprisingly, surviving neurons were found that lacked Bcl-x immunoreactivity, thereby demonstrating that this gene is dispensable for the ongoing survival of a subpopulation of catecholaminergic cells.
引用
收藏
页码:6721 / 6728
页数:8
相关论文
共 51 条
  • [1] Bcl-xL protects adult septal cholinergic neurons from axotomized cell death
    Blömer, U
    Kafri, T
    Randolph-Moore, L
    Verma, IM
    Gage, FH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) : 2603 - 2608
  • [2] BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH
    BOISE, LH
    GONZALEZGARCIA, M
    POSTEMA, CE
    DING, LY
    LINDSTEN, T
    TURKA, LA
    MAO, XH
    NUNEZ, G
    THOMPSON, CB
    [J]. CELL, 1993, 74 (04) : 597 - 608
  • [3] Staging of brain pathology related to sporadic Parkinson's disease
    Braak, H
    Del Tredici, K
    Rüb, U
    de Vos, RAI
    Steur, ENHJ
    Braak, E
    [J]. NEUROBIOLOGY OF AGING, 2003, 24 (02) : 197 - 211
  • [4] Molecular pathways of neurodegeneration in Parkinson's disease
    Dawson, TM
    Dawson, VL
    [J]. SCIENCE, 2003, 302 (5646) : 819 - 822
  • [5] FUNCTION AND EXPRESSION OF THE BCL-X GENE IN THE DEVELOPING AND ADULT NERVOUS-SYSTEM
    FRANKOWSKI, H
    MISSOTTEN, M
    FERNANDEZ, PA
    MARTINOU, I
    MICHEL, P
    SADOUL, R
    MARTINOU, JC
    [J]. NEUROREPORT, 1995, 6 (14) : 1917 - 1921
  • [6] Transgenic mice engineered to target Cre/LoxP-mediated DNA recombination into catecholaminergic neurons
    Gelman, DM
    Noaín, D
    Avale, ME
    Otero, V
    Low, MJ
    Rubinstein, M
    [J]. GENESIS, 2003, 36 (04) : 196 - 202
  • [7] BCL-X IS EXPRESSED IN EMBRYONIC AND POSTNATAL NEURAL TISSUES AND FUNCTIONS TO PREVENT NEURONAL CELL-DEATH
    GONZALEZGARCIA, M
    GARCIA, I
    DING, LY
    OSHEA, S
    BOISE, LH
    THOMPSON, CB
    NUNEZ, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) : 4304 - 4308
  • [8] NEUROPATHOLOGY OF IMMUNOHISTOCHEMICALLY IDENTIFIED BRAIN-STEM NEURONS IN PARKINSONS-DISEASE
    HALLIDAY, GM
    LI, YW
    BLUMBERGS, PC
    JOH, TH
    COTTON, RGH
    HOWE, PRC
    BLESSING, WW
    GEFFEN, LB
    [J]. ANNALS OF NEUROLOGY, 1990, 27 (04) : 373 - 385
  • [9] Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease
    Hartmann, A
    Mouatt-Prigent, A
    Vila, M
    Abbas, N
    Perier, C
    Faucheux, BA
    Vyas, S
    Hirsch, EC
    [J]. NEUROBIOLOGY OF DISEASE, 2002, 10 (01) : 28 - 32
  • [10] bcl-XL is critical for dendritic cell survival in vivo
    Hon, H
    Rucker, EB
    Hennighausen, L
    Jacob, J
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (07) : 4425 - 4432